-
What makes decentralisation the future of clinical trials?
November 14, 2022 |With the emergence of COVID-19, Decentralisation of Clinical Trials became necessary to comply with social distancing requirements while carrying out clinical research. Over the past few years, the clinical trial landscape has shifted its focus to patient-centric practices to promote patient ...
INSIGHTS
-
BlogHow eCOA Improves Patient Experience and Data QualityOctober 17, 2022 -
BlogIWRS/IRT/RTSM: Are they different or the same?October 3, 2022 -
BlogClinical Data Management: What Are The Key Challenges And How To Navigate Them?June 24, 2022 -
BlogAI and Automation in Clinical TrialsMay 12, 2022
-
BlogTop 9 Features to Look for While Choosing an eClinical PlatformApril 27, 2022 -
BlogBenefits of Using an Electronic Data Capture (EDC) System in Clinical TrialsMarch 25, 2022 -
BlogHow can AIML help Clinical Data Managers improve trial efficacySeptember 29, 2021 -
Blog4 Benefits of using Clinion eCOASeptember 29, 2020 -
BlogClinion is supporting researchers in their fight against the Covid-19 pandemic.May 31, 2020 -
BlogWhy Implement an FDA 21 CFR Part 11 Software SystemJanuary 23, 2020 -
BlogBenefits of a Clinical Trial Management SystemJanuary 20, 2020 -
BlogImplementing a Clinical Data Management System (CDMS)November 27, 2019